Allergy Therapeutics plc

Allergy Therapeutics plc - Enterprise Valueverified

AGYTF

Price:

$0.15

Market Cap:

$252.10M

Allergy Therapeutics plc is a biotechnology firm dedicated to the research, development, and commercialization of innovative treatments for allergic conditions. The company offers a variety of allergen-specific immunotherapies, available as both injectable solutions and sublingual (under-the-tongue) formulations. Their product line includes prescription medications specifically designed to address pollen-related allergies, such as those caused by grasses, weeds, and trees, along with various diagnostic tools. Key products in their portfolio feature names like Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Pollinex, VLP Peanut, and Penicillin diagnostics. Furthermor...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2010-02-03

Stock Exchange

OTC

Ticker

AGYTF

The Enterprise Value as of August 2026 (TTM) for Allergy Therapeutics plc (AGYTF) is 268.77M

According to Allergy Therapeutics plc’s latest financial reports and current stock price. The company's current Enterprise Value is 268.77M. This represents a change of -30.48% compared to the average of 386.61M of the last 4 quarters.

Allergy Therapeutics plc (AGYTF) Historical Enterprise Value (quarterly & annually)

How has AGYTF Enterprise Value performed in the past?

The mean historical Enterprise Value of Allergy Therapeutics plc over the last ten years is 92.40M. The current 268.77M Enterprise Value has changed 28.99% with respect to the historical average. Over the past ten years (40 quarters), AGYTF's Enterprise Value was at its highest in in the December 2025 quarter at 591.39M. The Enterprise Value was at its lowest in in the December 2019 quarter at 3.01M.

Quarterly (TTM)
Annual

Average

92.40M

Median

49.55M

Minimum

17.20M

Maximum

426.23M

Allergy Therapeutics plc (AGYTF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Allergy Therapeutics plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 695.72%

Maximum Annual Enterprise Value = 426.23M

Minimum Annual Increase = -73.39%

Minimum Annual Enterprise Value = 17.20M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025426.23M119.70%
2024194.01M695.72%
202324.38M-52.59%
202251.42M6.76%
202148.17M160.28%
202018.51M7.59%
201917.20M-73.39%
201864.64M26.93%
201750.93M78.35%
201628.55M-18.74%

Allergy Therapeutics plc (AGYTF) Average Enterprise Value

How has AGYTF Enterprise Value performed in the past?

The current Enterprise Value of Allergy Therapeutics plc (AGYTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

214.87M

5-year avg

148.84M

10-year avg

92.40M

Allergy Therapeutics plc (AGYTF) Enterprise Value vs. Peers

How is AGYTF’s Enterprise Value compared to its peers?

Allergy Therapeutics plc’s Enterprise Value is less than Verano Holdings Corp. (410.80M), less than Glass House Brands Inc. (0), greater than ManifestSeven Holdings Corporation (22.25M), less than Cresco Labs Inc. (752.38M), less than Boiron S.A. (429.61M), less than JCR Pharmaceuticals Co., Ltd. (103.95B), less than MedinCell S.A. (905.34M), less than YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (12.86B), less than Hua Medicine (Shanghai) Ltd. (1.23B), greater than Lattice Biologics Ltd. (3.09M),

Build a custom stock screener for Allergy Therapeutics plc (AGYTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allergy Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Allergy Therapeutics plc (AGYTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Allergy Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Allergy Therapeutics plc's Enterprise Value?

What is the highest Enterprise Value for Allergy Therapeutics plc (AGYTF)?

What is the 3-year average Enterprise Value for Allergy Therapeutics plc (AGYTF)?

What is the 5-year average Enterprise Value for Allergy Therapeutics plc (AGYTF)?

How does the current Enterprise Value for Allergy Therapeutics plc (AGYTF) compare to its historical average?